Science Explorer Back to mapMap
Discussion
Company · Burlingame · United States

Humanigen (United States)

humanigen.comROR OpenAlex
Research works
21
▼ 48% vs 2018-21
Citations
1.2k
56.0 per fractional work
Top-10% rate
4.8%
all institutions 10.0%
Open access
57%
world 40%
International
24%
world 18%
Humanigen (United States)

Not ranked overall: Humanigen (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Humanigen (United States) work in?

In all years, 47% of research at Humanigen (United States) is in Life Sciences, 47% in Health Sciences. Its largest fields are Medicine (47%), Biochemistry, Genetics and Molecular Biology (39%), Immunology and Microbiology (5%). It does 2.1× the world's share of Life Sciences.

Life Sciences: 10 fractional works · 46.8% of its workBiochemistry, Genetics and Molecular Biology: 8 fractional works · 38.9% of its workMolecular Biology: 4 fractional works · 21.5% of its workGenetics: 3 fractional works · 12.9% of its workCancer Research: 1 fractional works · 3.8% of its workBiotechnology: 0 fractional works · 0.6% of its workImmunology and Microbiology: 1 fractional works · 4.7% of its workImmunology: 1 fractional works · 3.8% of its workVirology: 0 fractional works · 0.8% of its workAgricultural and Biological Sciences: 1 fractional works · 3.3% of its workPlant Science: 0 fractional works · 2.4% of its workAgronomy and Crop Science: 0 fractional works · 0.8% of its workHealth Sciences: 10 fractional works · 46.7% of its workMedicine: 10 fractional works · 46.5% of its workInfectious Diseases: 2 fractional works · 10.0% of its workOncology: 2 fractional works · 7.9% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 5.0% of its workNeurology: 1 fractional works · 3.9% of its workPulmonary and Respiratory Medicine: 1 fractional works · 3.0% of its workEpidemiology: 1 fractional works · 3.0% of its workGenetics: 0 fractional works · 2.3% of its workPharmacology: 0 fractional works · 2.0% of its workHematology: 0 fractional works · 2.0% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 1.6% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 1.6% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 1.3% of its workSurgery: 0 fractional works · 0.9% of its workPhysiology: 0 fractional works · 0.5% of its workPathology and Forensic Medicine: 0 fractional works · 0.5% of its workEmergency Medicine: 0 fractional works · 0.3% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 0.3% of its workImmunology and Allergy: 0 fractional works · 0.3% of its workNursing: 0 fractional works · 0.2% of its workNutrition and Dietetics: 0 fractional works · 0.2% of its workPhysical Sciences: 1 fractional works · 4.9% of its workComputer Science: 1 fractional works · 3.9% of its workComputer Vision and Pattern Recognition: 1 fractional works · 3.9% of its workEngineering: 0 fractional works · 1.0% of its workElectrical and Electronic Engineering: 0 fractional works · 0.7% of its workBiomedical Engineering: 0 fractional works · 0.3% of its workSocial Sciences: 0 fractional works · 1.7% of its workArts and Humanities: 0 fractional works · 0.8% of its workLanguage and Linguistics: 0 fractional works · 0.8% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.8% of its workEconomics and Econometrics: 0 fractional works · 0.8% of its workALL ITS WORKHumanigen (UnitedStates)21fractional works, all years
Life Sciences47%Physical Sciences5%Health Sciences47%Social Sciences2%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 9 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology838.9%
    2. Immunology and Microbiology14.7%
    3. Agricultural and Biological Sciences13.3%
    1. Medicine1046.5%
    2. Nursing00.2%
    1. Computer Science13.9%
    2. Engineering01.0%
    1. Arts and Humanities00.8%
    2. Economics, Econometrics and Finance00.8%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Humanigen (United States)?

Ranked on the quality score, Cameron Durrant, Dale Chappell and Adrian Kilcoyne lead among researchers whose main affiliation is Humanigen (United States).

  1. 1 Cameron Durrant United States · #1,248,502 worldwide 1.1k citations · 39 works
  2. 2 Dale Chappell United States · #1,396,300 worldwide 966 citations · 33 works
  3. 3 Adrian Kilcoyne United States · #1,571,800 worldwide 437 citations · 194 works
  4. 4 Gabrielle Chappell United States · #2,016,570 worldwide 284 citations · 21 works
  5. 5 E. O. Jordan United States · #3,454,170 worldwide 79 citations · 17 works
All ranked researchers at Humanigen (United States)

What are the most cited papers from Humanigen (United States)?

The most cited paper from Humanigen (United States) is "GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts" (Rosalie M. Sterner et al., 2018), with 640 citations. Next come "α-Skeletal and α-Cardiac Actin Genes Are Coexpressed in Adult Human Skeletal Muscle and Heart" (234) and "GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia" (89).

Most cited papers
#PaperReleasedCitations
1 GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts Rosalie M. Sterner et al. · Blood Open access 22 Nov 2018 640
2 α-Skeletal and α-Cardiac Actin Genes Are Coexpressed in Adult Human Skeletal Muscle and Heart Peter William Gunning, Phyllis A. Ponte, Helen M. Blau et al. · Molecular and Cellular Biology Open access Nov 1983 234
3 GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia Zelalem Temesgen et al. · Mayo Clinic Proceedings Open access 3 Sep 2020 89
4 Cardiac Actin Is the Major Actin Gene Product in Skeletal Muscle Cell Differentiation In Vitro William Bains, Phyllis A. Ponte, Helen M. Blau et al. · Molecular and Cellular Biology Aug 1984 74
5 Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial Zelalem Temesgen et al. · The Lancet Respiratory Medicine Open access124 authors Dec 2021 74
All 32 most cited papers, with filters and sorting

Which keywords describe research at Humanigen (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Genomic Integration, Embryonic Stem Cells, Pandemic, ACE2 Receptor, SARS-CoV-2, Gene Expression, Immunotherapy and Gene Therapy.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 24 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 24 words, with their numbers
  1. Genomic Integration2▲ 118×2 topics
  2. Embryonic Stem Cells2▲ 149×2 topics
  3. Pandemic2▲ 24×3 topics
  4. ACE2 Receptor2▲ 87×2 topics
  5. Gene Expression2▲ 16×3 topics
  6. SARS-CoV-22▲ 69×2 topics
  7. Immunotherapy2▲ 14×4 topics
  8. Epidemiology2▲ 2.2×4 topics
  9. Biopharmaceutical Production2▲ 103×2 topics
  10. Gene Therapy2▲ 32×3 topics
  11. Genetic Modification2▲ 199×1 topic
  12. Immune Response2▲ 12×3 topics
  13. Transgenic Animals2▲ 199×1 topic
  14. Cancer Immunotherapy1▲ 47×2 topics
  15. Genome Engineering1▲ 118×1 topic
  16. RNA-Guided1▲ 118×1 topic
  17. CAR T Cells1▲ 141×1 topic
  18. Chimeric Antigen Receptor1▲ 141×1 topic
  19. Tumor Regression1▲ 74×2 topics
  20. Clinical Characteristics1▲ 88×1 topic
  21. Thrombosis1▲ 27×1 topic
  22. Vaccine1▲ 14×3 topics
  23. Global Collaboration1▲ 119×1 topic
  24. Health Biotechnology1▲ 256×1 topic

Which research topics does Humanigen (United States) publish most on?

By volume in 2022-now: COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Cancer-related molecular mechanisms research and Cancer Genomics and Diagnostics.

COVID-19 Clinical Resear…1COVID-19 Clinical Research Studies: 1 fractional worksSARS-CoV-2 and COVID-19 Research: 0 fractional worksCancer-related molecular…0Cancer-related molecular mechanisms research: 0 fractional worksCancer Genomics and Diag…0Cancer Genomics and Diagnostics: 0 fractional worksSingle-cell and spatial transcriptomics: 0 fractional worksLong-Term Effects of COVID-19: 0 fractional worksCAR-T cell therapy resea…0CAR-T cell therapy research: 0 fractional worksSepsis Diagnosis and Tre…0Sepsis Diagnosis and Treatment: 0 fractional worksCOVID-19 and healthcare …0COVID-19 and healthcare impacts: 0 fractional worksHealth Systems, Economic…0Health Systems, Economic Evaluations, Quality of Life: 0 fractional works
Infectious DiseasesCancer ResearchMolecular BiologyNeurology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 COVID-19 Clinical Research Studies Infectious Diseases 1 works
  2. 2 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
  3. 3 Cancer-related molecular mechanisms research Cancer Research 0 works
  4. 4 Cancer Genomics and Diagnostics Cancer Research 0 works
  5. 5 Single-cell and spatial transcriptomics Molecular Biology 0 works
  6. 6 Long-Term Effects of COVID-19 Neurology 0 works
  7. 7 CAR-T cell therapy research Oncology 0 works
  8. 8 Sepsis Diagnosis and Treatment Epidemiology 0 works
  9. 9 COVID-19 and healthcare impacts Oncology 0 works
  10. 10 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available57.4%not open42.6%

World: 40% of research is openly available.

with international co-authors23.8%domestic only76.2%

World: 18% is written across borders.

How has Humanigen (United States)'s research output changed?

Output in 2022-2025 was 48% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Humanigen (United States) as a percentage of every work published that year, 0.0000046% in 2023.

still counting0.000050%0.00010%Humanigen (United States)0.000017% in 20251990200020102020

Fractional works of Humanigen (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Burlingame

All research institutions in Burlingame

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Humanigen (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.